By day 28, 70% of recipients of remdesivir plus standard care and 53% who received standard care alone had been released from the hospital, a 16% difference.
Remdesivir tied to 54% lower risk of death among hospitalized COVID patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows